*Some Market data delayed by 15 mins.

Zevra Therapeutics, Inc. Common Stock

Symbol: ZVRA (NASDAQ)
9.63 ▲ (1.10%) 0.105

Company Description:
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Key Stats
  • Today's Open: $9.585
  • Today's High: $9.924
  • Today's Low: $9.51
  • Today's Volume: 2.53M
  • Yesterday Close: $9.52
  • Yesterday High: $9.955
  • Yesterday Low: $8.9245
  • Yesterday Volume: 7.16M
  • Last Min Volume: 2
  • Last Min High: $9.625
  • Last Min Low: $9.592
  • Last Min VWAP: $9.592
Company Profile
  • Name: Zevra Therapeutics, Inc. Common Stock
  • Website: https://www.zevra.com
  • Listed Date: 2015-04-16
  • Location: CELEBRATION, FL
  • Market Status: Active
  • CIK Number: 0001434647
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $548.44M
  • Round Lot: 100
  • Outstanding Shares: 56.14M
  • Asset Type: CS
RECENT FILINGS FOR ZVRA
Filing Date Filing Type Format
2025-09-16 4 View
2025-09-15 4 View
2025-08-20 4 View
2025-08-12 10-Q View
2025-08-12 8-K View
2025-06-30 4 View
2025-06-26 144 View
2025-06-24 4 View
2025-05-30 4 View
2025-05-30 4 View
2025-05-30 4 View
2025-05-30 4 View
2025-05-30 4 View
2025-05-30 4 View
2025-05-30 4 View
2025-05-29 8-K View
2025-05-21 DEFA14A View
2025-05-13 10-Q View
2025-05-13 8-K View
2025-05-08 DEFA14A View
Latest News on ZVRA

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.